Search All UT System Experts

IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation

Stephen P. Hack, Jessica Spahn, Minshan Chen, Ann Lii Cheng, Ahmed Kaseb, Masatoshi Kudo, Han Chu Lee, Adam Yopp, Pierce Chow, Shukui Qin

Research output: Contribution to journal › Review article › peer-review

128 Scopus citations

Fingerprint

Dive into the research topics of 'IMbrave 050: A Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation'. Together they form a unique fingerprint.

Medicine & Life Sciences